Aiforia Technologies

Aiforia Technologies is a digital pathology company founded in 2013 as a spin-off from the Finnish Institute for Molecular Medicine and headquartered in Helsinki, Finland, building AI software that analyzes tissue slide images to support cancer diagnosis and pathology research.

Its CE-IVD marked clinical suites score digitized slides for breast, lung, prostate, gastric and colon cancer, while the Aiforia Create tool lets research teams build and validate their own deep-learning image models; hospital networks, research organizations and pharmaceutical companies such as the AP-HP hospital group, the NHS and Sanofi use the platform for quantitative slide review and drug-development studies.

1. Clinical Diagnostic Suites: AI scores digitized tissue slides for several major cancer types.

2. Custom Model Building: Aiforia Create lets teams train their own deep-learning image models.

3. Quantitative Overlays: Results are shown as visual overlays directly on the digital slide.

4. Cloud Collaboration: Pathologists and researchers review cases together in one cloud workspace.

5. Research Workflows: GLP-compliant tools automate image analysis for preclinical studies.

6. Regulatory Standing: Clinical products carry CE-IVD marking and ISO 13485 certification.